Back to Startups

Comphya

About Comphya

A clinical-stage MedTech company advancing an implantable neurostimulation therapy for erectile dysfunction (ED) unresponsive to medication.

Business Information
Target Customers
patients with erectile dysfunction healthcare providers urologists
Industry Categories
Bioscience & Disease Healthcare Systems Personal Health
Business Model
Revenue Model Medical device sales
Pricing Strategy Not publicly disclosed
Sales Channels direct sales, medical distributors
Funding Timeline
Round Date Amount Investors
Series A Jul 08, 2025 Undisclosed Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
finSMEs
FinSMEs @finSMEs
Jul 08, 2025

Comphya, a Lausanne, Switzerland-based clinical-stage MedTech company advancing an implantable neurostimulation therapy for erectile dysfunction (ED) unresponsive to medication, closed a Series A financing round https://t.co/MsOFQ2mfLt

vc_chatgpt
VC Guru @vc_chatgpt
Jul 08, 2025

๐Ÿข Comphya ๐Ÿ“ Lausanne, Switzerland ๐Ÿ—๏ธ Healthcare & Life Sciences ๐Ÿ’ฐ $9.39M Series A ๐Ÿ”— https://t.co/5kJLWWfipM ๐Ÿ“ Comphya SA, a Lausanne-based MedTech company founded in 2017, has successfully closed an oversubscribed Series A financing round, raising a total of โ‚ฌ8 million,

raisingfi
Raising.fi @raisingfi
Jul 08, 2025

New Raise ๐Ÿ›๏ธ Company: Comphya ๐Ÿ”— Website: https://t.co/ayQPLRnUqE ๐Ÿ“Š Amount: $7.58 Million ๐Ÿ”„ Round: Series A ๐Ÿงฎ Valuation: N/A โš™๏ธ Industry: Medical Technology

venturelab_ch
Venturelab @venturelab_ch
Jul 09, 2025

Comphya secured CHF 7.5 millionin Series A round, an exciting milestone for this Venture Leaders alumni and TOP 100 Swiss Startups ranker! https://t.co/QREWAGPwEo Comphya is developing CaverSTIM, the first implantable neurostimulator for erectile dysfunction in patients https://t.co/c8K9YrV7wk

venturelab_ch
Venturelab @venturelab_ch
Jul 09, 2025

Comphya's oversubscribed CHF 7.5 million Series A round, an exciting milestone for this Venture Leaders alumni and TOP 100 Swiss Startups ranker! https://t.co/QREWAGQ4tW Comphya is developing CaverSTIM, the first implantable neurostimulator for erectile dysfunction in patients https://t.co/Bpvh4HUEtv